Skip to main content
. 2020 Jan 1;16(3):471–482. doi: 10.7150/ijbs.39123

Figure 5.

Figure 5

Diagnostic efficiency of individual or combined exosomal lncRNAs for NSCLC. (A-B) ROC curve analysis for exosomal lncRNAs in distinguishing NSCLCs overall or stage I NSCLC patients versus healthy controls. (C-D) ROC curve analysis for exosomal lncRNAs for ADC patients or SCC patients versus healthy controls.